LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells.
To elucidate the mechanisms by which Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappa B in nasopharyngeal carcinoma cells. A tetracycline-regulated LMP1-expressing nasopharyngeal carcinoma cell line, Tet-on-LMP1-HNE2, was used as the cell model. The kinetics of the expression of proteins, including LMP1, I kappa B alpha and I kappa B beta, was analyzed by Western blotting. The subcellular localization of NF-kappa B (p65) was detected by indirect immunofluorescence assay. The NF-kappa B transactivity was studied by transient transfection and reporter gene assay. I kappa B alpha was phosphorylated and degraded after the inducible expression of LMP1, although the total protein levels remained stable. The steady-state level of total I kappa B beta protein may have resulted from the initiation of an autoregulation loop after the activation of NF-kappa B. No change in the I kappa B beta level was detected. NF-kappa B (p65) was translocated from the cytoplasm to the nucleus following degradation of I kappa B alpha. After the introduction of the dominant-negative mutant of I kappa B alpha (Del 71) into Tet-on-LMP1-HNE2 cells, both nuclear translocation and transactivation of NF-kappa B induced by LMP1 was significantly inhibited. The results indicated that in nasopharyngeal carcinoma cells, LMP1 activated NF-kappa B via phosphorylation and degradation of I kappa B alpha, but not I kappa B beta. The dominant-negative mutant of I kappa B alpha (Del 71) could completely inhibit both the nuclear translocation and transactivation of NF-kappa B induced by LMP1.